PortfoliosLab logo

Akebia Therapeutics, Inc. (AKBA)

Equity · Currency in USD · Last updated Jun 28, 2022

Company Info

ISINUS00972D1054
CUSIP00972D105
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$0.37
Year Range$0.32 - $3.88
EMA (50)$0.56
EMA (200)$1.67
Average Volume$10.32M
Market Capitalization$67.03M

AKBAShare Price Chart


Chart placeholderClick Calculate to get results

AKBAPerformance

The chart shows the growth of $10,000 invested in Akebia Therapeutics, Inc. on Mar 21, 2014 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $140 for a total return of roughly -98.60%. All prices are adjusted for splits and dividends.


AKBA (Akebia Therapeutics, Inc.)
Benchmark (^GSPC)

AKBAReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M0.32%-6.21%
YTD-83.44%-18.17%
6M-85.21%-17.47%
1Y-91.09%-8.89%
5Y-52.69%10.04%
10Y-40.34%9.29%

AKBAMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

AKBASharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Akebia Therapeutics, Inc. Sharpe ratio is -0.88. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


AKBA (Akebia Therapeutics, Inc.)
Benchmark (^GSPC)

AKBADividend History


Akebia Therapeutics, Inc. doesn't pay dividends

AKBADrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


AKBA (Akebia Therapeutics, Inc.)
Benchmark (^GSPC)

AKBAWorst Drawdowns

The table below shows the maximum drawdowns of the Akebia Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Akebia Therapeutics, Inc. is 98.91%, recorded on May 24, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.91%Jun 23, 20141996May 24, 2022
-36.84%Mar 21, 201416Apr 11, 20145Apr 21, 201421
-21.82%Apr 22, 201420May 19, 201414Jun 9, 201434
-4.91%Jun 10, 20146Jun 17, 20143Jun 20, 20149

AKBAVolatility Chart

Current Akebia Therapeutics, Inc. volatility is 99.19%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


AKBA (Akebia Therapeutics, Inc.)
Benchmark (^GSPC)

Portfolios with Akebia Therapeutics, Inc.


Loading data...